Grafa News and Videos — Page 202

Embraer (NYSE:EMBJ) reported Q2 2026 revenue of $2.235 billion, up 23% year over year, as aircraft deliveries increased and firm order backlog reached a record $34.5 billion.

AirSculpt Technologies (NASDAQ:AIRS) reported Q2 2026 revenue of $42.9 million, down 3%, while case volume declined 0.5% to 3,376 procedures and adjusted EBITDA fell to $4.9 million.

BeOne Medicines (NASDAQ:ONC) and Revolution Medicines (NASDAQ:RVMD) announced a multi-part oncology collaboration combining clinical research programs with a regional rights agreement covering four RAS(ON) inhibitors in selected Asian markets.

Dole (NYSE:DOLE) reported Q2 2026 revenue of $2.499 billion, up 2.9%, while net income increased to $35.1 million from $18 million.

ChipMOS Technologies (NASDAQ:IMOS) reported unaudited July 2026 revenue of NT$2.823 billion (US$87.5 million), up 43.6% year over year and 11.2% sequentially.

National Energy Services Reunited (NASDAQ:NESR) reported Q2 2026 revenue of $520.8 million, up 59.1% year over year, while net income increased to $44.0 million.

Barrick Mining (NYSE:B) reported Q2 2026 revenue of $5.29 billion, up 44% year over year, while expanding its Nevada Gold Mines joint venture with Newmont through a revised ownership structure.

Innate Pharma (NASDAQ:IPHA) announced plans to begin the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma, subject to completion of its strategic partnership with Sobi.

ASE Technology Holding (NYSE:ASX) reported unaudited July 2026 net revenue of NT$73.8 billion, up 43.2% year over year and 12.2% from June 2026.

Oculis (NASDAQ:OCS) signed an agreement to acquire worldwide development and commercial rights to Privosegtor (ACT-01) from Accure Therapeutics, along with rights to an early-stage neurology candidate known as ACT-02.